Tilak Healthcare, an innovative Paris, France-based ophthalmological digital health company, has successfully secured €10 million in funding, boosting its total funding to €22 million. The funding round was spearheaded by Elaia and Cap Hornet, featuring notable participation from iBionext, SWEN Capital Partners, Théa, Adelie, and angel investors including Yann Fleureau. This funding infusion is poised to accelerate the product rollout of Tilak Healthcare's pioneering platform, OdySight, not only within France but also on the global stage, while further expanding its product portfolio dedicated to addressing chronic vision disorders.